Related Experiment Video
Updated: Sep 10, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Organochlorine Pesticide Residues in Children with Hematological Disorders
Rachit Khandelwal1, Sumaira Khalil1, Vipin Tyagi2
1Department of Pediatrics, University College of Medical Sciences and GTB Hospital, New Delhi, Delhi, India.
Insights
Children with hematological disorders (HDs) have higher organochlorine pesticide (OCP) residues in their blood and bone marrow. Malignant HDs showed higher OCP levels than non-malignant HDs, indicating a potential environmental link.
Area of Science:
- Environmental Health
- Pediatric Hematology
- Toxicology
Background:
- Organochlorine pesticides (OCPs) are persistent environmental pollutants.
- Exposure to OCPs has been linked to various health issues.
- Limited data exists on OCP levels in children with hematological disorders (HDs).
Purpose of the Study:
- To compare OCP residue levels in sera and bone marrow of children with malignant and non-malignant HDs.
- To compare OCP levels in these children with healthy controls.
Main Methods:
- A case-control study involving children aged 12 years or younger.
- Included children with malignant HDs, non-malignant HDs, and healthy controls.
- OCPs were quantified in serum and bone marrow aspirates using gas-liquid chromatography/electron capture detection.
Main Results:
- Serum OCP levels were significantly higher in children with malignant and non-malignant HDs compared to controls.
- Malignant HDs exhibited higher serum OCP levels than non-malignant HDs.
- Specific OCPs like hexachlorocyclohexane and endosulfan showed differential levels between HD groups and in bone marrow.
Conclusions:
- Children with HDs have significantly elevated OCP residues in their sera compared to healthy children.
- Cumulative OCP residues in sera and bone marrow are higher in children with malignant HDs versus non-malignant HDs.
- Findings suggest a potential association between OCP exposure and the development or progression of pediatric hematological disorders.
Objectives:
To compare the levels of organochlorine pesticide (OCP) residues in sera and bone marrow of children with malignant and non-malignant hematological disorders (HDs) with those in healthy controls.
Methods:
This case-control study was conducted among children aged ≤ 12 years with malignant and non-malignant HDs and non-anemic healthy controls. Children with gross congenital malformations, neurodevelopmental disorders, and chronic systemic diseases were excluded. OCPs were estimated in sera and bone marrow aspirate using gas-liquid chromatography/63Ni electron capture detection.
Results:
Thirty children, each, with malignant HDs, non-malignant HDs, and controls, were included. The median (Q1, Q3) serum total OCPs (ng/mL) were significantly higher in children with malignant and non-malignant HDs compared to controls [38.67 (33.64, 42.51); 32.72 (17.26, 41.60); and 14.11 (12.82, 16.40)]; levels were significantly higher in the malignant versus non-malignant HD group. The median (Q1, Q3) serum levels of total hexachlorocyclohexane [3.30 (2.23, 4.28) vs. 2.16 (1.31, 3.31) ng/mL] and β-hexachlorocyclohexane [0.98 (0.67, 1.68) vs. 0.54 (0.10, 0.77) ng/mL] levels were significantly higher in children with non-malignant HDs compared to malignant HD, respectively. The median (Q1, Q3) total bone marrow OCPs (ng/mL) were significantly higher in the malignant HD group [23.53 (20.83, 26.91)] compared to the non-malignant HD group [17.41 (0, 25.63)]; bone marrow endosulfan II (ng/mL) was significantly higher in the non-malignant HD group [1.56 (0.56, 3.89)] compared to malignant HD group [0.45 (0.35, 1.72)].
Conclusion:
Children with HDs had significantly higher OCP residues in sera compared to controls. The cumulative OCP residues in sera and bone marrow were significantly higher in children with malignant versus non-malignant HDs.
More Related Videos
04:17Analysis of Organochlorine Pesticides in a Soil Sample by a Modified QuEChERS Approach Using Ammonium Formate
Published on: January 20, 2023
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
The Periodic Table and Organismal Elements
Periodic Table Provides Information...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...